NMDA receptors: from genes to channels

https://doi.org/10.1016/S0165-6147(96)80008-3Get rights and content

Abstract

N-methyl-D-aspartate receptors belong to the family of ionotropic glutamate receptors. NMDA receptors were named after the specific glutamate-like synthetic agonist N-methyl-D-aspartate. In the past decade, an increasing number of functional sites have been discovered and used to refine the operational definition of NMDA receptors. The goal to characterize the molecular substrate underlying the heretofore strictly operationally defined NMDA receptors has come into reach following the cloning of a number of cDNAs coding for NMDA receptor subunits. However, in their review, Nikolaus Sucher and colleagues show that caution should be exercised in comparing the pharmacological properties of recombinant NMDA receptors to those of native neurones. Future work on NMDA receptors will be challenged to reconcile disparate effects obtained with recombinant versus native receptors.

References (67)

  • P.H. Seeburg

    Trends Neurosci.

    (1993)
  • T. Ishii

    J. Biol. Chem.

    (1993)
  • R.A.J. McIlhinney et al.

    Neuroscience

    (1996)
  • F.A. Boeckman et al.

    Neurosci. Lett.

    (1994)
  • R. Zukin et al.

    Trends Neurosci.

    (1995)
  • M. Hollmann

    Neuron

    (1993)
  • R. MacKinnon

    Neuron

    (1995)
  • D. Forrest

    Neuron

    (1994)
  • Y. Li et al.

    Cell

    (1994)
  • T. Kutsuwada

    Neuron

    (1996)
  • K. Ikeda

    Mol. Brain Res.

    (1995)
  • H. Monyer et al.

    Neuron

    (1994)
  • J.M. Sullivan

    Neuron

    (1994)
  • G. Köhr et al.

    Neuron

    (1994)
  • M. Yamazaki et al.

    FEBS Lett.

    (1992)
  • P.L. Chazot et al.

    J. Biol. Chem.

    (1994)
  • P. Paoletti et al.

    Neuron

    (1995)
  • B. Suchanek et al.

    J. Biol. Chem.

    (1995)
  • Z.G. Wo et al.

    J. Biol. Chem.

    (1995)
  • M. Hollmann et al.

    Neuron

    (1994)
  • M.D. Ehlers et al.

    Cell

    (1996)
  • E. Aizenman et al.

    Neuron

    (1989)
  • H. Gozlan et al.

    Trends Pharmacol. Sci.

    (1995)
  • S.Z. Lei

    Neuron

    (1992)
  • S.A. Lipton et al.

    Trends Pharmacol. Sci.

    (1996)
  • N. Brose et al.

    J. Biol. Chem.

    (1993)
  • N.J. Sucher

    J. Biol. Chem.

    (1993)
  • Y. Ben-Ari et al.

    Neurosci. Lett.

    (1988)
  • U.V. Berger et al.

    Neuroscience

    (1995)
  • D. Zhang et al.

    Neuroscience

    (1995)
  • S.A. Lipton et al.

    New Engl. J. Med.

    (1994)
  • S. Nakanishi

    Science

    (1992)
  • M. Hollmann et al.

    Annu. Rev. Neurosci.

    (1994)
  • Cited by (285)

    • The bioactivity of neuronal-derived nitric oxide in aging and neurodegeneration: Switching signaling to degeneration

      2021, Free Radical Biology and Medicine
      Citation Excerpt :

      The fact that activation of NMDAr increased intracellular cGMP levels was already known at the time [63] and not long after this, •NO was shown to be produced upon receptor activation and responsible for the Ca2+-dependent increase in cGMP [6,64]. The NMDAr is a voltage-sensitive ligand-gated non-selective cation channel permeable to Ca2+ [65]. All NMDAr subtypes are tetramers comprising 2 obligatory GluN1 subunits and 2 copies of GluN2 and/or GluN3 subunits.

    • Endogenous dynorphins, glutamate and N-methyl-d-aspartate (NMDA) receptors may participate in a stress-mediated Type-I auditory neural exacerbation of tinnitus

      2013, Brain Research
      Citation Excerpt :

      In terms of their overall function, NMDA receptors are tightly regulated post-synaptic, ligand-gated ion channels that are permeable to the cations Na+, K+ (Hollmann and Heinemann, 1994; Popescu, 2005a, 2005b) and especially Ca++ (McBain and Mayer, 1994; Popescu et al., 2010; Traynelis et al., 2010; Wisden et al., 2000). NMDA receptor agonists consist of short-chain dicarboxylic amino acids such as glutamate, aspartate and NMDA itself, with glutamate being the most potent of these agonists (Dingledine et al., 1999; Monaghan et al., 1989; Sucher et al., 1996). Allosteric modulation is defined simply as the receptor modulation that occurs when the binding of one agonist affects the subsequent binding affinities of other substances (co-agonists) at their respective binding sites on the same receptor complex.

    • Combined treatment with capsaicin and resveratrol enhances neuroprotection against glutamate-induced toxicity in mouse cerebral cortical neurons

      2012, Food and Chemical Toxicology
      Citation Excerpt :

      Glutamate is a major excitatory amino acid neurotransmitter in the central nervous system (CNS) involved in fast synaptic transmission, neuronal plasticity, outgrowth and survival, as well as memory, learning and behavior (Sucher et al., 1996).

    View all citing articles on Scopus
    View full text